BioNexus Gene Lab(BGLC)现在的股价是多少？ BioNexus Gene Lab现在的股价报0.3047 BioNexus Gene Lab的股票在哪间交易所挂牌交易？ BioNexus Gene Lab的股票在纳斯达克挂牌交易。 BioNexus Gene Lab的股票代码是什么？ BioNexus Gene Lab的股票代码是“BGLC。” BioNexus Gene ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH Whitepaper.

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

Board of Directors has formally approved the Company’s new Ethereum (ETH)-focused treasury strategy. Concurrently, ...

BioNexus Gene Lab Corporation (BGLC) shares tumbled to a 52-week low, touching down at $0.22, with a price-to-book ratio of just... ByInvesting.com • Dec 20, 2024 BGLC stock touches 52-week low ...

吉隆坡 - 纳斯达克上市医疗科技公司BioNexus Gene Lab Corp. (NASDAQ: BGLC)，市值588万美元，年收入926万美元，最近在其财务管理方面做出战略性调整，正式批准将以太坊 (ETH)作为其主要财务资产。这一举措使BGLC成为纳斯达克交易所首家专注于以太坊进行财务管理的公司。根据 InvestingPro ...